(Q39296065)

English

The effects of dutasteride, tamsulosin, and the combination on storage and voiding in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the Combination of Avodart and Tamsulosin study.

scientific article published on September 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19901936%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

The effects of dutasteride, tamsulosin, and the combination on storage and voiding in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the Combination of Avodart and Tamsulosin study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19901936%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

prostatic hypertrophy

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19901936%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

E Becher

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19901936%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

C G Roehrborn

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19901936%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

R P Gagnier

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19901936%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

T H Wilson

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19901936%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

F Montorsi

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19901936%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

1 September 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19901936%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Prostate Cancer and Prostatic Diseases

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19901936%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19901936%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19901936%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

369-374

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19901936%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.37

31 March 2020

Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.37

31 March 2020

A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care setting

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.37

31 March 2020

Muscarinic receptor antagonists for overactive bladder

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.37

31 March 2020

Management of benign prostate hyperplasia: an overview of alpha-adrenergic antagonist

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.37

31 March 2020

alpha-Blockade improves symptoms suggestive of bladder outlet obstruction but fails to relieve it.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.37

31 March 2020

Managing the progression of lower urinary tract symptoms/benign prostatic hyperplasia: therapeutic options for the man at risk

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.37

31 March 2020

5alpha-reductase inhibition for men with enlarged prostate

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.37

31 March 2020

Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.37

31 March 2020

The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.37

31 March 2020

The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.37

31 March 2020

Combination therapy with dutasteride and tamsulosin in men with moderate-to-severe benign prostatic hyperplasia and prostate enlargement: the CombAT (Combination of Avodart and Tamsulosin) trial rationale and study design

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.37

31 March 2020

The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the Comb

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.37

31 March 2020

Impact of LUTS Using Bother Index in DAN-PSS-1 Questionnaire

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.37

31 March 2020

Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.37

31 March 2020

The detrusor muscle: an innocent victim of bladder outlet obstruction.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.37

31 March 2020

Long-term treatment with finasteride results in a clinically significant reduction in total prostate volume compared to placebo over the full range of baseline prostate sizes in men enrolled in the MTOPS trial

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.37

31 March 2020

Modulation of voiding and storage reflexes by activation of alpha1-adrenoceptors

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.37

31 March 2020

alpha(1)-Adrenoceptor selectivity and the treatment of benign prostatic hyperplasia and lower urinary tract symptoms

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.37

31 March 2020

Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.37

31 March 2020

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39296065&oldid=2202757025"